GSTM1 and anemia: (2) The team of Ashorn, Per from Finland found that the provision of SQ-LNS reduced the prevalence of anemia (Hb < 110 g/L) by 16% (a relative reduction) and could significantly reduce childhood anemia, iron deficiency, and iron deficiency anemia (82).